Mario Karolyi - Infectious Diseases

Author Information

Mario Karolyi is associated with the Department for Infectious Diseases at Kaiser-Franz-Josef-Hospital (KFJ) in Vienna, Austria. His research work is primarily focused on infectious diseases, with a special interest in COVID-19, as evidenced by his recent publications on the subject. His affiliation at KFJ Hospital suggests a strong clinical background and a role in evaluating and managing infectious diseases in a hospital setting.

Research Contributions

Mario Karolyi has made significant contributions to the field of infectious diseases, particularly in the context of the COVID-19 pandemic. His research includes the evaluation of antigen tests for SARS-CoV-2, understanding the pharmacokinetics of antibiotics in experimental models, and developing predictive models for COVID-19 mortality. Additionally, his work has addressed the thrombotic complications associated with COVID-19, the role of diabetes in COVID-19 mortality, and the comparison of COVID-19 with influenza. This diverse range of studies highlights his extensive involvement in both the clinical and research aspects of infectious diseases.

Aliases

Mario Karolyi is also known by the aliases M Karolyi and M. Karolyi. These variations are commonly used in his publications and academic references.

Publication and Citation Metrics

Metric	Value
Total Papers	55
Total Citations	757
H-index	15

Publications:

Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting

DOI: 10.1007/s11606-022-07448-x

Year: 2022

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model

DOI: 10.3389/fphar.2021.702455

Year: 2021

A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation

DOI: 10.3389/fcimb.2021.795026

Year: 2021

Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications

DOI: 10.3389/fcvm.2021.802566

Year: 2021

Cutaneous manifestations of SARS-CoV-2: A 2-center, prospective, case-controlled study

DOI: 10.1016/j.jaad.2021.03.064

Year: 2021

COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age—Propensity Score-Matched Analysis of Austrian National Public Health Institute Data

DOI: 10.3390/v13122401

Year: 2021

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5

DOI: 10.3389/fcvm.2021.779073

Year: 2021

Management of hospitalized influenza A patients during the season 2018/19

DOI: 10.1007/s00508-021-01950-8

Year: 2021

COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria

DOI: 10.1007/s15010-021-01610-z

Year: 2021

Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report

DOI: 10.1007/s42399-020-00683-5

Year: 2021

What are the clinical features of infections caused by Flaviviridae?

How Can Cervical Cancer Be Controlled Globally?

What Factors Influence Prevalence?

What Are the Considerations for Treating Parasitic Infections?

How is AIDS Diagnosed?

When Are Antimalarial Drugs Used?

What Are the Challenges in Controlling Aedes Aegypti?

What Types of Infections Can PCR Detect?

What is Dengue Hemorrhagic Fever?

What Are Some Examples of Inherited Immunity?

Partnered Content Networks

Relevant Topics